Secretory CYTL1 enhances MAPK/ERK pathway activation through C-C chemokine receptor type 2 in chronic granulocytic leukemia (CMML) (CCR2). The gene discussed is CCR2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.